Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis

PHASE3CompletedINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

June 8, 2018

Study Completion Date

June 8, 2018

Conditions
Strongyloidiasis
Interventions
DRUG

Ivermectin

oral formulation

Trial Locations (9)

37024

Centro per le Malattie Tropicali, Ospedale Sacro Cuore, Negrar

Unknown

Clinica di Malattie Infettive e Tropicali, Brescia

UFDID, Azienda Ospedaliero-universitaria Careggi, Florence

Unità di Malattie Infettive, Anna Meyer Children's Universisty Hospital, Florence

Unidad de Medicina, Hospital de Poniente-El Ejido, El Ejido

FCRB, Hospital Clinic de Barcelona, Barcelona

Unitat Medicina Tropical i Salut Internacional Drassanes, Barcelona

Addenbrookes Hospital, Cambridge University Hospital, Cambridge

UCLH, London

All Listed Sponsors
collaborator

European Commission

OTHER

lead

Centro per le Malattie Tropicali

OTHER

NCT01570504 - Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis | Biotech Hunter | Biotech Hunter